Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kazuo Umemura
Effects of Vapiprost, a Novel Thromboxane Receptor Antagonist, on Thrombus Formation and Vascular Patency After Thrombolysis by Tissue-Type Plasminogen Activator
British Journal of Pharmacology
Pharmacology
Tissue-Type Plasminogen Activator Has Paradoxical Roles in Focal Cerebral Ischemic Injury by Thrombotic Middle Cerebral Artery Occlusion With Mild or Severe Photochemical Damage in Mice
Journal of Cerebral Blood Flow and Metabolism
Neurology
Cardiovascular Medicine
Cardiology
‹
1
2
Related publications
Thrombolysis of Canine Femoral Artery Thrombus by a Novel Modified Tissue-Type Plasminogen Activator (E6010).
The Japanese Journal of Pharmacology
Role of Thrombin and Thromboxane A2 in Reocclusion Following Coronary Thrombolysis With Tissue-Type Plasminogen Activator.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Acute Coronary Thrombolysis With Recombinant Human Tissue-Type Plasminogen Activator: Initial Patency and Influence of Maintained Infusion on Reocclusion Rate
American Journal of Cardiology
Cardiovascular Medicine
Cardiology
Kistrin, a Polypeptide Platelet GPIIb/IIIa Receptor Antagonist, Enhances and Sustains Coronary Arterial Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Canine Preparation
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Thrombolysis of Subarachnoid Clot Using Tissue Plasminogen Activator
Surgery for Cerebral Stroke
Coronary Thrombolysis With Facilitated Absorption of Intramuscularly Injected Tissue-Type Plasminogen Activator.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Effect of Thrombolysis on Myocardial Injury: Recombinant Tissue Plasminogen Activator vs. Alfimeprase
American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular Medicine
Physiology
Cardiology
Novel Actions of Tissue-Type Plasminogen Activator in Chronic Kidney Disease
Frontiers in Bioscience - Landmark
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Early Thrombolysis by Recombinant Tissue-Plasminogen Activator Is Beneficial to the Ischemic Myocardium.
Journal of Pharmacobio-Dynamics